Comparison 3. LUNA versus LPSN.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Pain relief ‐ up to 6 months | 1 | 68 | Odds Ratio (M‐H, Fixed, 95% CI) | 0.67 [0.17, 2.61] |
1.1 Primary dysmenorrhoea | 1 | 68 | Odds Ratio (M‐H, Fixed, 95% CI) | 0.67 [0.17, 2.61] |
2 Pain relief ‐ up to 12 months | 1 | 68 | Odds Ratio (M‐H, Fixed, 95% CI) | 0.10 [0.03, 0.32] |
2.1 Primary dysmenorrhoea | 1 | 68 | Odds Ratio (M‐H, Fixed, 95% CI) | 0.10 [0.03, 0.32] |
3 Adverse effects | 1 | Peto Odds Ratio (Peto, Fixed, 95% CI) | Subtotals only | |
3.3 Primary dysmenorrhoea | 1 | 68 | Peto Odds Ratio (Peto, Fixed, 95% CI) | 0.02 [0.01, 0.06] |